Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal
Filter by:
Why Cellect's Federal Circuit Case Is One To Watch
December 16, 2022
Members Adam Samansky and Peter Cuomo spoke to Managing IP on the implications that a pending case in the Court of Appeals for the Federal Circuit could have on litigation and prosecution strategies for life sciences companies.
'Caremark' Liability Following The SEC's New ESG Reporting Requirements
December 15, 2022
Members Douglas P. Baumstein, Jacob H. Hupart, and Securities & Capital Markets Chair and Life Sciences Co-Chair Jonathan L. Kravetz, and Associates Will G. McKitterick and Ellen Shapiro authored an article for the New York Law Journal analyzing the role corporate boards play in monitoring and overseeing a company's operations, particularly in light of the SEC's imminent ESG disclosure rules.
Mintz’s Drew DeVoogd Wins Boston Patent Law Association’s Pro Bono Award
December 15, 2022
Mintz's Bob Bodian On RTO, Partner Expectations And All Those Associates
December 15, 2022
Managing Member Bob Bodian sat down for an interview with The American Lawyer to talk about Mintz, in particular return to office, associate hiring, the 2022 market, and what 2023 will have in store.
Mintz Represents NET Power on $1.459 Billion Business Combination with Rice Acquisition Corp. II
December 14, 2022
BOSTON – Mintz advised NET Power, LLC, a clean energy technology company whose proprietary technology delivers clean, reliable and low-cost power from natural gas, in its planned business combination with Rice Acquisition Corp II (NYSE: RONI), a special purpose acquisition company (SPAC).
HHS Pans Pfizer's 'Far-Fetched' Kickback Views At High Court
December 14, 2022
Mintz Member Laurence J. Freedman spoke to Law360 about the awaited brief from the U.S. Department of Health and Human Services on whether Anti-Kickback Statute cases should show whether health care "remuneration" intentionally impacted medical decision making.